Импетиго (поверхностная пиодермия)

Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261.Полный текст  Аннотация

1. Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014 Aug 15;90(4):229-35.Полный текст  Аннотация

2. Bowen AC, Mahé A, Hay RJ, et al. The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma. PLoS One. 2015 Aug 28;10(8):e0136789.Полный текст  Аннотация

3. Elliot AJ, Cross KW, Smith GE, et al. The association between impetigo, insect bites and air temperature: a retrospective 5-year study (1999-2003) using morbidity data collected from a sentinel general practice network database. Fam Pract. 2006 Oct;23(5):490-6.Полный текст  Аннотация

4. Kakar N, Kumar V, Mehta G, et al. Clinico-bacteriological study of pyodermas in children. J Dermatol. 1999 May;26(5):288-93. Аннотация

5. Tewodros W, Muhe L, Daniel E, et al. A one-year study of streptococcal infections and their complications among Ethiopian children. Epidemiol Infect. 1992 Oct;109(2):211-25. Аннотация

6. Loffeld A, Davies P, Lewis A, et al. Seasonal occurrence of impetigo: a retrospective 8-year review (1996-2003). Clin Exp Dermatol. 2005 Sep;30(5):512-4. Аннотация

7. Kristensen JK. Scabies and pyoderma in Lilongwe, Malawi. Prevalence and seasonal fluctuation. Int J Dermatol. 1991 Oct;30(10):699-702. Аннотация

8. Durupt F, Mayor L, Bes M, et al. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br J Dermatol. 2007 Dec;157(6):1161-7. Аннотация

9. Shi D, Higuchi W, Takano T, et al. Bullous impetigo in children infected with methicillin-resistant Staphylococcus aureus alone or in combination with methicillin-susceptible S. aureus: analysis of genetic characteristics, including assessment of exfoliative toxin gene carriage. J Clin Microbiol. 2011 May;49(5):1972-4. Аннотация

10. Hay R, Adriaans B. Bacterial infections. In: Burns T, Breathnach S, Cox N, et al., eds. Rook's textbook of dermatology. 7th ed. Malden, MA: Blackwell Science; 2004:1221-306.

11. Amagai M, Matsuyoshi N, Wang ZH, et al. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med. 2000 Nov;6(11):1275-7. Аннотация

12. Hanakawa Y, Schechter NM, Lin C, et al. Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest. 2002 Jul;110(1):53-60.Полный текст  Аннотация

13. Weedon D. Weedon's skin pathology. 3rd ed. Oxford, UK: Churchill Livingstone, Elsevier; 2009:549.

14. Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD006207.Полный текст  Аннотация

15. Luby SP, Agboatwalla M, Feikin DR, et al. Effect of handwashing on child health: a randomised controlled trial. Lancet. 2005 Jul 16-22;366(9481):225-33. Аннотация

16. Scully BE, Briones F, Gu JW, et al. Mupirocin treatment of nasal staphylococcal colonization. Arch Intern Med. 1992 Feb;152(2):353-6. Аннотация

17. Raz R, Miron D, Colodner R, et al. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med. 1996 May 27;156(10):1109-12. Аннотация

18. Darmstadt GL, Osendarp SJ, Ahmed S, et al. Effect of antenatal zinc supplementation on impetigo in infants in Bangladesh. Pediatr Infect Dis J. 2012 Apr;31(4):407-9. Аннотация

19. Turnidge J, Collignon P. Resistance to fusidic acid. Int J Antimicrob Agents. 1999 Aug;12 Suppl 2:S35-44. Аннотация

20. Dagan R, Bar-David Y. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 1992 Feb;36(2):287-90.Полный текст  Аннотация

21. Kwak YG, Choi SH, Kim T, et al. Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infect Chemother. 2017 Dec;49(4):301-25.Полный текст  Аннотация

22. Tasani M, Tong SY, Andrews RM, et al. The importance of scabies coinfection in the treatment considerations for impetigo. Pediatr Infect Dis J. 2016 Apr;35(4):374-8. Аннотация

23. Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261.Полный текст  Аннотация

24. Wallin TR, Hern HG, Frazee BW. Community-associated methicillin-resistant Staphylococcus aureus. Emerg Med Clin North Am. 2008 May;26(2):431-55. Аннотация

25. National Institute for Health and Care Excellence. Impetigo: antimicrobial prescribing. February 2020 [internet publication].Полный текст

26. Koning S, van der Wouden JC, Chosidow O, et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br J Dermatol. 2008 May;158(5):1077-82. Аннотация

27. Vogel A, Lennon D, Best E, et al. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. N Z Med J. 2016 Oct 14;129(1443):77-83. Аннотация

28. Rosen T, Albareda N, Rosenberg N, et al. Efficacy and safety of ozenoxacin cream for treatment of adult and pediatric patients with impetigo: a randomized clinical trial. JAMA Dermatol. 2018 Jul 1;154(7):806-13. Аннотация

29. Gropper S, Albareda N, Chelius K, et al; Ozenoxacin in Impetigo Trial Investigators Group. Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial. Future Microbiol. 2014;9(9):1013-23. Аннотация

30. Barton LL, Friedman AD. Impetigo: a reassessment of etiology and therapy. Pediatr Dermatol. 1987 Nov;4(3):185-8. Аннотация

31. Noguchi N, Nishijima S, Kurokawa I, et al. Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome. J Clin Microbiol. 2006 Jun;44(6):2119-25. Аннотация

32. Bowen AC, Tong SY, Andrews RM, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet. 2014 Dec 13;384(9960):2132-40. Аннотация

33. McLinn S. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo. J Am Acad Dermatol. 1990 May;22(5 Pt 1):883-5. Аннотация

34. Abbas M, Paul M, Huttner A. New and improved? A review of novel antibiotics for Gram-positive bacteria. Clin Microbiol Infect. 2017 Oct;23(10):697-703. Аннотация

35. Bassetti M, Della Siega P, Pecori D, et al. Delafloxacin for the treatment of respiratory and skin infections. Expert Opin Investig Drugs. 2015 Mar;24(3):433-42. Аннотация

36. Chamny S, Miron D, Lumelsky N, et al. Topical minocycline foam for the treatment of impetigo in children: results of a randomized, double-blind, phase 2 study. J Drugs Dermatol. 2016 Oct 1;15(10):1238-43. Аннотация